Date of management change: March 02, 2022
, -based OncoMyx Therapeutics Appointed Robert Williamson as Chief Business and Chief Financial Officer.
OncoMyx Therapeutics targets hematologic and solid tumors with unique oncolytic virus called myxoma (MYXV) and a novel patented systemic delivery approach.
Robert Williamson is Chief Business and Chief Financial Officer. at OncoMyx Therapeutics. Previously, Robert held various senior HR leadership roles in the industry.
News
Short ProfileName: Robert Williamson
Title: Chief Business and Chief Financial Officer.
Company: OncoMyx Therapeutics
Industry: Residential and Long-Term Care Facilities
Current Contact InfoEmail: *****************@oncomyx.com
Phone:.***
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Kollmer Dillon, Teixeira Bender Katherine, Pia Patricia, Pepler Cara, Konitzer Karri, Odekirk Theresa, Martinez Rich, Morin-Scribner Nicole, Baldassarre Joe, Rassback Cindy, Cate Ashley
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
